These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 17899308

  • 21. Parotid irrigation and cevimeline gargle for treatment of xerostomia in Sjögren's syndrome.
    Takagi Y, Katayama I, Tashiro S, Nakamura T.
    J Rheumatol; 2008 Nov; 35(11):2289-91. PubMed ID: 19004065
    [No Abstract] [Full Text] [Related]

  • 22. Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations.
    von Bültzingslöwen I, Sollecito TP, Fox PC, Daniels T, Jonsson R, Lockhart PB, Wray D, Brennan MT, Carrozzo M, Gandera B, Fujibayashi T, Navazesh M, Rhodus NL, Schiødt M.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103 Suppl():S57.e1-15. PubMed ID: 17379156
    [Abstract] [Full Text] [Related]

  • 23. General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 3rd communication: effects on respiratory and cardiovascular systems.
    Arisawa H, Fukui K, Masunaga H.
    Arzneimittelforschung; 2002 Mar; 52(3):162-7. PubMed ID: 11963642
    [Abstract] [Full Text] [Related]

  • 24. Xerostomia secondary to Sjögren's syndrome in the elderly: recognition and management.
    Al-Hashimi I.
    Drugs Aging; 2005 Mar; 22(11):887-99. PubMed ID: 16323968
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The therapy of Sjogren's syndrome: a review.
    Coaccioli S, Giuliani M, Puxeddu A.
    Clin Ter; 2007 Mar; 158(5):453-6. PubMed ID: 18062353
    [Abstract] [Full Text] [Related]

  • 27. Pilocarpine and artificial saliva for the treatment of xerostomia and xerophthalmia in Sjögren syndrome: a double-blind randomized controlled trial.
    Cifuentes M, Del Barrio-Díaz P, Vera-Kellet C.
    Br J Dermatol; 2018 Nov; 179(5):1056-1061. PubMed ID: 29432648
    [Abstract] [Full Text] [Related]

  • 28. General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 2nd communication: effects on somatic nervous system and on autonomic nervous system and smooth muscle.
    Arisawa H, Fukui K, Fujise N, Masunaga H.
    Arzneimittelforschung; 2002 Nov; 52(2):81-8. PubMed ID: 11878203
    [Abstract] [Full Text] [Related]

  • 29. A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome.
    Khurshudian AV.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):38-44. PubMed ID: 12539025
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 1st communication: effects on general behavior and central nervous system.
    Arisawa H, Imai E, Fujise N, Fukui K, Masunaga H.
    Arzneimittelforschung; 2002 Jan; 52(1):14-20. PubMed ID: 11838269
    [Abstract] [Full Text] [Related]

  • 33. Use of cevimeline, a muscarinic M1 and M3 agonist, in the treatment of Sjögren's syndrome.
    Fox RI.
    Adv Exp Med Biol; 2002 Jan; 506(Pt B):1107-16. PubMed ID: 12614037
    [No Abstract] [Full Text] [Related]

  • 34. Effect of a muscarinic M3 receptor agonist on gastric motility.
    Chiba T, Kudara N, Sato M, Inomata M, Orii S, Suzuki K.
    J Gastroenterol Hepatol; 2007 Nov; 22(11):2039-41. PubMed ID: 17914991
    [Abstract] [Full Text] [Related]

  • 35. Efficacy of cevimeline vs. pilocarpine in the secretion of saliva: a pilot study.
    Brimhall J, Jhaveri MA, Yepes JF.
    Spec Care Dentist; 2013 Nov; 33(3):123-7. PubMed ID: 23600983
    [Abstract] [Full Text] [Related]

  • 36. Effects of pilocarpine hydrochloride and cevimeline on submandibular/sublingual salivation in rat xerostomia model produced by X-ray irradiation.
    Omori Y, Asari T, Maruyama K, Kusama H, Kojima M, Shibata N.
    Arzneimittelforschung; 2003 Nov; 53(5):342-50. PubMed ID: 12854361
    [Abstract] [Full Text] [Related]

  • 37. Efficacy and safety of orally administered pilocarpine hydrochloride for patients with juvenile-onset Sjögren's syndrome.
    Tomiita M, Takei S, Kuwada N, Nonaka Y, Saito K, Shimojo N, Kohno Y.
    Mod Rheumatol; 2010 Oct; 20(5):486-90. PubMed ID: 20517630
    [Abstract] [Full Text] [Related]

  • 38. Effects of cevimeline on the immunolocalization of aquaporin-5 and the ultrastructure of salivary glands in Sjögren's syndrome model mice.
    Nishimura H, Yakeishi A, Saga T, Yamaki K.
    Kurume Med J; 2009 Oct; 56(3-4):39-47. PubMed ID: 20505281
    [Abstract] [Full Text] [Related]

  • 39. The use of oral pilocarpine in xerostomia and Sjögren's syndrome.
    Nusair S, Rubinow A.
    Semin Arthritis Rheum; 1999 Jun; 28(6):360-7. PubMed ID: 10406404
    [Abstract] [Full Text] [Related]

  • 40. Pilocarpine treatment in a mixed cohort of xerostomic patients.
    Aframian DJ, Helcer M, Livni D, Robinson SD, Markitziu A, Nadler C.
    Oral Dis; 2007 Jan; 13(1):88-92. PubMed ID: 17241436
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.